Capital Wealth Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$281K Hold
243
– – 0.12% 87
2026
Q2
$291K Buy
243
+1
+0.4% +$1.02K 0.14% 83
2026
Q1
$223K Hold
242
– – 0.1% 86
2025
Q4
$253K Buy
+242
New +$231K 0.11% 76
2024
Q2
– Sell
-260
Closed -$203K – 111
2024
Q1
$203K Buy
+260
New +$185K 0.12% 98
2020
Q1
– Sell
-245
Closed -$34K – 220
2019
Q4
$34K Buy
+245
New +$28.4K 0.03% 161

Other funds holding LLY

Capital Wealth Alliance's LLY Position: Q3 2026 in Review

Capital Wealth Alliance held its Eli Lilly (LLY) position steady in Q3 2026 at 243 shares worth $281K. The position accounts for 0.12% of the portfolio, ranked #87.

Capital Wealth Alliance first reported a position in LLY in Q4 2019 and has held it in 6 quarters since. The position peaked at $291K in Q2 2026. 4,262 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capital Wealth Alliance held 243 shares of Eli Lilly worth $281K as of Q3 2026.
  • Capital Wealth Alliance left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.12% of Capital Wealth Alliance's portfolio in Q3 2026, its #87 holding.
  • Capital Wealth Alliance first reported a position in Eli Lilly in Q4 2019 and has held it in 6 quarters since.
  • Capital Wealth Alliance's Eli Lilly position peaked at $291K in Q2 2026.
  • 4,262 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital Wealth Alliance's 13F filing for Q3 2026, filed 20 Oct 2026.